Skip to main content

IMVT

Stock
Health Care
Biotechnology

Performance overview

IMVT Price
Price Chart

Forward-looking statistics

Beta
1.01
Risk
58.17%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).

Company info

SectorHealth Care
IndustryBiotechnology
Employees154
Market cap$3.7B

Fundamentals

Enterprise value$2.0B
Revenue$0.0
Revenue per employee—
Profit margin0.00%
Debt to equity0.01

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$2.73
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$24M
Avg trading volume (10 day)$23M
Put-call ratio—

Macro factor sensitivity

Growth+4.9
Credit+1.3
Liquidity-3.0
Inflation+1.6
Commodities+0.9
Interest Rates-1.6

Valuation

Dividend yield0.00%
PEG Ratio-5.59
Price to sales—
P/E Ratio-5.59
Enterprise Value to Revenue—
Price to book4.08

Upcoming events

Next earnings dayMay 29, 2025
Next dividend day—
Ex. dividend day—

News

Immunovant (IMVT) Upgraded to Buy: What Does It Mean for the Stock?

Immunovant (IMVT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research (June 2, 2025)
Top 2 Health Care Stocks That May Collapse This Quarter

As of Sept. 9, 2024, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga (September 9, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free